Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 2/20 | 0.46 |
| ▸ | RORA | P35398 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ITGA1 | P56199 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17068902 | 0.98 | RORA (0.42) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL31267454 | 0.98 | RORA (0.42) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL20794264 | 0.96 | S100A4 (0.48) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL24123203 | 0.86 | RORC (0.50) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL30701881 | 0.86 | RORC (0.50) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL22947541 | 0.84 | CYP1A2 (0.42) | S100A4RORARORCGPR3KDM4E | |
| SCHEMBL27394818 | 0.83 | RORA (0.34) | S100A4RORARORCGPR3 | |
| SCHEMBL27394633 | 0.82 | CYP2A6 (0.43) | S100A4RORARORCGPR3CYP2A6 | |
| SCHEMBL27394478 | 0.81 | PDK2 (0.43) | RORARORCPDK2 | |
| SCHEMBL22884223 | 0.80 | CYP1A2 (0.47) | KDM4ENPC1ALDH1A1RAB9APDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-20210104673-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2021-04-08 | — | — | US | disclosed |
| US-10916708-B2 | Condensed cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10916708-B2 | Condensed cyclic compound and organic light emitting device including the same | C1S, C9, CCNT1 | S100A4 2890/4885RORA 1928/4885RORC 2318/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | S100A4 2739/4885RORA 2029/4885RORC 2466/4885 |
| US-20210104673-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | C1S, CCNT1, C9 | S100A4 2739/4885RORA 2029/4885RORC 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.